SNCA and diffuse large B-cell lymphoma: Immunotherapy is effective in a subset of DLBCL patients; however, the efficacy of anti‐PD‐1/PD‐L1 blockade remains unproven in a large number of patients, even in tumors with PD‐L1 expression.15, 16